Rubicon Research Private Limited v. Kartha Pharmaceuticals Inc. et al
Rubicon Research Private Limited |
Manoj Babu Mazhuvancheril and Kartha Pharmaceuticals Inc. |
3:2021cv00129 |
March 30, 2021 |
US District Court for the Western District of North Carolina |
Defend Trade Secrets Act of 2016 (DTSA) |
Plaintiff |
Docket Report
This docket was last retrieved on January 28, 2022. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 5 MEMORANDUM in Support re #4 MOTION for Preliminary Injunction and Expedited Discovery by Rubicon Research Private Limited. (Fulton, Ross) |
Filing 4 MOTION for Preliminary Injunction and Expedited Discovery by Rubicon Research Private Limited. Responses due by 4/13/2021 (Fulton, Ross) |
Filing 3 MOTION for Leave to Appear Pro Hac Vice as to Ann E. Querns Filing fee $ 288, receipt number 0419-4963437. by Rubicon Research Private Limited. (Fulton, Ross) |
Filing 2 MOTION for Leave to Appear Pro Hac Vice as to Leigh Ann Buziak Filing fee $ 288, receipt number 0419-4963435. by Rubicon Research Private Limited. (Fulton, Ross) |
Filing 1 COMPLAINT For Damages, Injunctive, and Other Relief against All Defendants with Jury Demand ( Filing fee $ 402 receipt number 0419-4963426), filed by Rubicon Research Private Limited.(Fulton, Ross) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.